DTL
EWTX icon

Dynamic Technology Lab’s Edgewise Therapeutics EWTX Stock Holding History

Dynamic Technology Lab’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,294
Closed -$101K – 1216
2022
Q4 		$101K Buy
+11,294
New +$106K 0.01% 992
2022
Q2 		– Sell
-12,923
Closed -$125K – 1254
2022
Q1 		$125K Buy
+12,923
New +$166K 0.01% 990

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dynamic Technology Lab's EWTX Position: Q1 2023 in Review

Dynamic Technology Lab sold out of Edgewise Therapeutics (EWTX) in Q1 2023, closing a stake of 11,294 shares — an estimated $101K sold.

Dynamic Technology Lab first reported a position in EWTX in Q1 2022 and held it in 2 quarters. The position peaked at $125K in Q1 2022. 85 funds tracked by Wall St. Rank hold EWTX as of Q1 2023.

  • Dynamic Technology Lab reported no remaining Edgewise Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 11,294 Edgewise Therapeutics shares in Q1 2023, an estimated $101K.
  • Dynamic Technology Lab first reported a position in Edgewise Therapeutics in Q1 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's Edgewise Therapeutics position peaked at $125K in Q1 2022.
  • 85 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2023.

Based on Dynamic Technology Lab's 13F filing for Q1 2023, filed 12 May 2023.